EUVIMEDEUVIMED entdecken
Open Access

Liver Failure, Hepatic Encephalopathy, and Infection Contribute to Mortality Risk in a Global Cirrhosis Cohort

Jasmohan S Bajaj, Scott Silvey, Aidan Mullan, Ashok Choudhury, Florence Wong, Jacob George, Ramazan Idilman, Mark Topazian, Wai-Kay Seto, Aldo Torre, Peter Hayes, Leroy R Thacker und 5 weitere

Clinical Gastroenterology and Hepatology · 2026-02 · 24 (2) · 453-462.e14

DOI: 10.1016/j.cgh.2025.06.021 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Gastroenterology and Hepatology, 2026-02. Verfasst von Jasmohan S Bajaj und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Virginia Commonwealth University, Richmond, Virginia. Electronic address: jasmohan.bajaj@vcuhealth.org. Hauptthemen laut MEDLINE: Hepatic Encephalopathy, Liver Cirrhosis, Infections, Liver Failure. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: CSRD VA, NCATS NIH HHS, University of Hong Kong.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND & AIMS: Validated cutoffs for liver failure with cirrhosis are required to define acute-on-chronic liver failure. We sought to determine the cutoff for serum bilirubin and international normalized ratio (INR), and influence of complications on inpatient mortality with the goal of defining liver failure and inpatient mortality prediction. METHODS: The derivation cohort for variables associated with mortality included 7239 patients with cirrhosis admitted nonelectively worldwide (CLEARED consortium) and followed until death/discharge. Admission variables, MELD 3.0, original MELD, and hepatic encephalopathy (HE) were used to create a decision rule to classify inpatient death using cutoffs to maximize negative predictive value and decision-tree models sorted each predictor's relative contribution. For external validation, data from 3 Mayo Clinic sites were used. RESULTS: A total of 7239 patients were included from 115 centers across 6 continents among whom 808 (11.2%) died in-hospital. Cutoffs maximizing negative predictive value for in-hospital transplant-free mortality were bilirubin ≤7.5 mg/dL, creatinine ≤1.5 mg/dL, INR ≤1.5, MELD ≤27, and MELD 3.0 ≤28. On decision tree analysis, the relative contributions to mortality were HE (42.2%), infection (22.2%), INR (18.6%), bilirubin (12.7), and creatinine (4.3%). Using only liver-specific variables, patients with bilirubin ≤7.5, INR ≤1.5, and without HE had only 3.3% mortality, whereas patients with bilirubin >7.5, INR >1.5, and HE had 33% mortality. External validation in 1634 patients from Mayo transplant evaluation cohort showed similar patterns for inpatient mortality prediction. CONCLUSIONS: Cutoffs associated with mortality are admission bilirubin >7.5 mg/dL, INR >1.5, creatinine >1.5 mg/dL, MELD >27, and MELD 3.0 >28. Liver failure may therefore be identified by the serum bilirubin >7.5 mg/dL and INR >1.5, with HE and admission infections as contributors toward mortality.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatic EncephalopathyLiver CirrhosisInfectionsLiver FailureHumansMaleFemaleMiddle AgedAgedBilirubinInternational Normalized RatioCohort StudiesAdultSurvival AnalysisRisk Assessment

Stichwörter der Autor:innen

Acute-On-Chronic Liver FailureBilirubinCLEARED ConsortiumGlobal RepresentationHepatic EncephalopathyInfectionsMELD 3.0Transplant

Substanzen

Bilirubin

Autor:innen und Institutionen

  • Department of Medicine, Virginia Commonwealth University, Richmond, Virginia. Electronic address: jasmohan.bajaj@vcuhealth.org.
  • Department of Medicine, Virginia Commonwealth University, Richmond, Virginia.
  • Department of Medicine, Mayo Clinic School of Medicine, Rochester, Minnesota.
  • Department of Medicine, Institute for Liver and Biliary Sciences, New Delhi, India.
  • Department of Medicine, University of Toronto, Toronto, Canada.
  • Department of Medicine, Storr Liver Centre, Westmead Millennium Institute, Westmead Hospital and University of Sydney, Sydney, Australia.

Förderung

  • CSRD VA
  • NCATS NIH HHS
  • University of Hong Kong
  • Universidade Federal do Rio Grande do Sul
  • King Chulalongkorn Memorial Hospital
  • Shandong University
  • Fudan University
  • Shanghai Jiao Tong University

Zitieren

APA

Bajaj, J. S., Silvey, S., Mullan, A., Choudhury, A., Wong, F., George, J., Idilman, R., Topazian, M., Seto, W. K., Torre, A., Hayes, P., Thacker, L. R., Bush, B. J., Alvares da Silva, M., Xie, Q., Kamath, P. S., & CLEARED Investigators (2026). Liver Failure, Hepatic Encephalopathy, and Infection Contribute to Mortality Risk in a Global Cirrhosis Cohort. Clinical Gastroenterology and Hepatology, 24(2), 453-462.e14. https://doi.org/10.1016/j.cgh.2025.06.021

Vancouver

Bajaj JS, Silvey S, Mullan A, Choudhury A, Wong F, George J, et al. Liver Failure, Hepatic Encephalopathy, and Infection Contribute to Mortality Risk in a Global Cirrhosis Cohort. Clinical Gastroenterology and Hepatology. 2026;24(2):453-462.e14. doi:10.1016/j.cgh.2025.06.021

BibTeX
@article{Bajaj2026,
  author = {Bajaj, Jasmohan S and Silvey, Scott and Mullan, Aidan and Choudhury, Ashok and Wong, Florence and George, Jacob and Idilman, Ramazan and Topazian, Mark and Seto, Wai-Kay and Torre, Aldo and Hayes, Peter and Thacker, Leroy R and Bush, Brian J and Alvares da Silva, Mario and Xie, Qing and Kamath, Patrick S and CLEARED Investigators, CLEARED Investigators},
  title = {Liver Failure, Hepatic Encephalopathy, and Infection Contribute to Mortality Risk in a Global Cirrhosis Cohort},
  journal = {Clinical Gastroenterology and Hepatology},
  year = {2026},
  volume = {24},
  number = {2},
  pages = {453--462.e14},
  doi = {10.1016/j.cgh.2025.06.021}
}
Kostenlos starten →